U.S. Household Products Stock News

As the U.S. stock market retreats from record highs, driven by a downturn in tech stocks, investors are reevaluating their strategies amidst fluctuating economic indicators and potential interest rate adjustments. In this climate, penny stocks remain an intriguing segment for those seeking growth opportunities outside the mainstream indices. Despite being considered a niche area of investment, these smaller or newer companies can offer significant returns when backed by robust financial...

As the U.S. markets experience a slight pullback from record highs, with tech stocks taking a hit and inflation concerns persisting, investors are increasingly looking beyond the giants of Wall Street to find opportunities in lesser-known small-cap companies. In this dynamic environment, identifying stocks that show potential for growth despite broader market fluctuations can be key to uncovering undiscovered gems within the U.S. market.

As the U.S. stock market experiences a pullback from record highs, driven by a decline in tech stocks, investors are increasingly turning their attention to more stable investment options like dividend stocks. In such an environment, dividend-paying stocks can offer a reliable income stream and potential for long-term growth, making them an attractive choice for those looking to navigate market volatility while benefiting from steady returns.

Over the past year, many Howmet Aerospace Inc. ( NYSE:HWM ) insiders sold a significant stake in the company which may...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

There's been a notable change in appetite for Marvell Technology, Inc. ( NASDAQ:MRVL ) shares in the week since its...

Despite an already strong run, CommScope Holding Company, Inc. ( NASDAQ:COMM ) shares have been powering on, with a...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...

In late August 2025, California lawmakers, Governor Gavin Newsom, Lyft, and Uber announced a landmark agreement enabling app-based drivers to unionize and bargain collectively while remaining classified as independent contractors, alongside regulatory reforms to reduce insurance mandates. This arrangement is considered the largest expansion of private sector collective bargaining rights in the state's history and has the potential to reshape labor relations and cost structures for gig...

Exxon Mobil recently reported its highest second quarter production since the company's founding, with more than half of output coming from high-return advantaged assets and announced expansion projects in China, Singapore, and the UK expected to generate over US$3 billion in earnings in 2026. This surge in production and focus on high-value assets mark a significant operational milestone and signal a potential shift in the company’s future earnings profile. We'll assess how these...

The MINISO Group Holding Limited ( NYSE:MNSO ) share price has done very well over the last month, posting an excellent...

American Express just made waves with a major partnership announcement, becoming the official payments partner at Hard Rock Stadium, the Miami Dolphins, and the Formula 1 Miami Grand Prix. This multi-year deal brings exclusive fan perks to eligible cardholders, from presale event tickets to dedicated lounges and entrances. For investors, this is not just marketing; it represents another step in Amex’s expansion of its global sports and entertainment footprint, aimed squarely at deepening...

Bruker recently reported a return on equity of 4.0%, well below the Life Sciences sector average of 11%, along with a debt-to-equity ratio of 1.32 that underscores its reliance on debt financing. This financial structure has sparked new concerns among investors about Bruker's exposure to financial risk and its resilience if credit conditions become more restrictive. We'll explore how investor anxieties about Bruker's low return on equity and high leverage may influence its future investment...

VICI Properties reported its fiscal Q2 2025 results in August, showing a 4.6% year-over-year increase in total revenues and a 16.7% increase in net income attributable to common stockholders. This performance highlights growing demand for VICI's diversified portfolio of hospitality, gaming, and entertainment assets, including flagship Las Vegas destinations. As VICI posted higher revenues and net income, we'll explore how these results affect the company's outlook for stable rent growth and...

Pfizer (PFE) just landed a significant regulatory win. On August 27, the company and its partner BioNTech announced that the U.S. Food and Drug Administration approved their updated LP.8.1-adapted monovalent COVID-19 vaccine. This new version is cleared for adults aged 65 and over, as well as younger high-risk individuals, thanks to clinical data showing it provides stronger immune protection against multiple newer COVID strains. For investors wondering where this leaves Pfizer as COVID...

Becton Dickinson recently reported lower-than-expected revenue in the past quarter, citing softness in its research instrument and diagnostics businesses because of reduced global research spending and tariffs. Despite these challenges, the company continues to generate cash and remains committed to shareholder value through ongoing stock buybacks and dividends. We’ll examine how Becton Dickinson’s revenue softness and ongoing shareholder returns may affect the company’s medium-term...

If you’ve been following fuboTV (NYSE:FUBO), you probably noticed the recent 3.3% pop in its share price following the announcement of Fubo Sports, a new standalone streaming plan designed specifically for sports fans. The new tier, set to launch September 2, aims to deliver a focused sports lineup at a lower price point, featuring over 20 national and local channels, plus bundled access to ESPN’s new direct-to-consumer Unlimited plan. This is a move to capture cost-conscious viewers and...

If you own shares of AbbVie or have been watching from the sidelines, the latest wave of clinical trial results may have just put the stock back on your radar. AbbVie has made headlines with positive updates across a handful of key programs, including encouraging data from its pivotal Phase 3 trial of upadacitinib (RINVOQ) in severe alopecia areata as well as early-stage progress in multiple cancer therapies. These developments, paired with upwardly revised earnings estimates, are fueling a...

It is not every day that investors in Berkshire Hathaway (BRK.A) wake up to big news from Omaha. Today’s headline is hard to ignore. Warren Buffett, the titan who has steered the company for decades, will soon hand over the CEO reins to Greg Abel. The announcement that Buffett will step aside as CEO caught the market’s attention, raising questions about leadership, strategy, and what it all means for shareholders. While Buffett plans to remain as chairman, this marks a historic transition for...

V.F (VFC) just got a confidence boost, with Baird upgrading the stock based on signs of a turnaround in the Vans brand, better product momentum, and clear progress on cost-cutting and debt management. This nod from analysts seems to have brightened investor spirits, especially as it lines up with the company’s announced changes to its revolving credit facility, giving them more financial flexibility to support their transformation plans. For shareholders on the sidelines, it is the kind of...

On August 20, 2025, scPharmaceuticals Inc. announced an amendment to its supply agreement with West Pharmaceutical Services, extending the term through December 31, 2027, and clarifying termination cost obligations for both parties. This update highlights both the ongoing relationship around West's SmartDose drug delivery system and the company's continued role as a key supplier in the injectable drug delivery market. We'll explore how the supply agreement extension and terms may impact West...

Wrangler and Coors Banquet recently launched their first-ever Wrangler x Coors Banquet Collection, featuring over twenty unique Western-inspired apparel pieces and a series of pop-up events across Dallas, Nashville, and Denver starting in late August 2025. This collaboration unites two classic American brands in a cross-industry product launch, highlighting both companies’ focus on storytelling, craftsmanship, and outreach to a broader, experience-driven customer base. We’ll examine how this...

Bio-Techne recently completed two share repurchase tranches, retiring a total of 1.24% and 2.76% of its outstanding shares, representing a combined capital return of approximately US$496.33 million as of June 2025. This large-scale buyback initiative underscores the company’s shareholder capital allocation priorities and may impact both earnings per share and investor sentiment going forward. We'll assess how Bio-Techne's completion of a US$100.05 million buyback could influence its...

On August 29, 2025, Reinsurance Group of America filed a shelf registration for a US$241.8 million common stock offering, allocating 1,250,000 shares for its Employee Stock Ownership Plan (ESOP). This ESOP-related capital raise highlights the company's commitment to employee ownership, potentially strengthening alignment between staff interests and long-term corporate performance. We'll examine how this ESOP-driven share offering could influence Reinsurance Group of America's outlook on...